Published in Nat Chem Biol on December 05, 2010
Enterohaemorrhagic Escherichia coli exploits a tryptophan switch to hijack host f-actin assembly. Structure (2012) 1.47
Signaling through dynamic linkers as revealed by PKA. Proc Natl Acad Sci U S A (2013) 1.28
Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII. Nat Chem Biol (2012) 1.08
Dimerization of mammalian kinesin-3 motors results in superprocessive motion. Proc Natl Acad Sci U S A (2014) 1.03
Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1. Mol Cell Biol (2011) 1.00
Protein conformational switches: from nature to design. Chemistry (2012) 0.99
Models of crk adaptor proteins in cancer. Genes Cancer (2012) 0.94
Complete determination of the Pin1 catalytic domain thermodynamic cycle by NMR lineshape analysis. J Biomol NMR (2011) 0.94
Cyclophilin A catalyzes proline isomerization by an electrostatic handle mechanism. Proc Natl Acad Sci U S A (2014) 0.92
NMR reveals novel mechanisms of protein activity regulation. Protein Sci (2011) 0.89
Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation. Oncogene (2011) 0.87
Pin1-Induced Proline Isomerization in Cytosolic p53 Mediates BAX Activation and Apoptosis. Mol Cell (2015) 0.83
Structural biology: CrkL is not Crk-like. Nat Chem Biol (2012) 0.82
Substrate-specific reorganization of the conformational ensemble of CSK implicates novel modes of kinase function. PLoS Comput Biol (2012) 0.81
The adaptor protein Crk in immune response. Immunol Cell Biol (2013) 0.81
Structure and activity of the peptidyl-prolyl isomerase domain from the histone chaperone Fpr4 toward histone H3 proline isomerization. J Biol Chem (2013) 0.81
Structural biology: The twist in Crk signaling revealed. Nat Chem Biol (2011) 0.81
Allosteric linkers in cAMP signalling. Biochem Soc Trans (2014) 0.81
Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies. Prion (2012) 0.80
Structure of the interleukin-2 tyrosine kinase Src homology 2 domain; comparison between X-ray and NMR-derived structures. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.79
AtFKBP16-1, a chloroplast lumenal immunophilin, mediates response to photosynthetic stress by regulating PsaL stability. Physiol Plant (2013) 0.79
Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk. Oncogene (2014) 0.78
Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway. Nat Chem Biol (2015) 0.77
Contribution of Crk adaptor proteins to host cell and bacteria interactions. Biomed Res Int (2014) 0.76
Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α. J Biol Chem (2015) 0.76
Molecular dynamics of the proline switch and its role in Crk signaling. J Phys Chem B (2014) 0.75
The Role of Crk Adaptor Proteins in T-Cell Adhesion and Migration. Front Immunol (2015) 0.75
Prolyl isomerization as a molecular memory in the allosteric regulation of the signal adapter protein c-CrkII. J Biol Chem (2014) 0.75
Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99
SH2 domains recognize specific phosphopeptide sequences. Cell (1993) 17.28
Specific incorporation of cyclophilin A into HIV-1 virions. Nature (1994) 7.13
A novel viral oncogene with structural similarity to phospholipase C. Nature (1988) 5.84
New tools provide new insights in NMR studies of protein dynamics. Science (2006) 4.64
NMR characterization of the dynamics of biomacromolecules. Chem Rev (2004) 4.44
Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol (2007) 3.45
Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature (2005) 3.18
Crk family adaptors-signalling complex formation and biological roles. Oncogene (2001) 3.11
Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J (2005) 2.79
c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J (1994) 2.68
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature (2006) 2.61
Dynamic activation of an allosteric regulatory protein. Nature (2009) 2.61
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev (1994) 2.54
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol Life Sci (1999) 2.50
Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell (2010) 2.44
Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol Cell (2007) 2.44
Structural basis for cAMP-mediated allosteric control of the catabolite activator protein. Proc Natl Acad Sci U S A (2009) 2.39
Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol (2007) 2.22
Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol (2005) 2.06
Weak alignment NMR: a hawk-eyed view of biomolecular structure. Curr Opin Struct Biol (2005) 2.02
Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell (2006) 1.93
Allosteric regulation of Hsp70 chaperones by a proline switch. Mol Cell (2006) 1.88
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal (2009) 1.79
Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure (1995) 1.76
Native state proline isomerization: an intrinsic molecular switch. Biochemistry (2003) 1.74
Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci U S A (2002) 1.71
Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biol Cell (2008) 1.52
Structural characterization of a proline-driven conformational switch within the Itk SH2 domain. Nat Struct Biol (2002) 1.42
Prolyl isomerization as a molecular timer in phage infection. Nat Struct Mol Biol (2005) 1.41
Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature (1995) 1.40
Structure of an ultraweak protein-protein complex and its crucial role in regulation of cell morphology and motility. Mol Cell (2005) 1.37
A regulatable switch mediates self-association in an immunoglobulin fold. Nat Struct Mol Biol (2008) 1.30
Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc Natl Acad Sci U S A (2002) 1.26
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene (2003) 1.20
Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J (1995) 1.19
The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene (1994) 1.09
A functional proline switch in cytochrome P450cam. Structure (2008) 1.05
C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF. J Cell Physiol (2005) 1.04
Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett (2002) 1.03
Prolyl cis-trans Isomerization as a molecular timer in Crk signaling. Mol Cell (2007) 1.01
Solution structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II. Biochemistry (2006) 1.00
Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells (2001) 1.00
Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain. Oncogene (2005) 0.98
Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain. J Mol Biol (2009) 0.96
Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene (2006) 0.96
Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene (2001) 0.92
CrkII signals from epidermal growth factor receptor to Ras. Proc Natl Acad Sci U S A (1996) 0.88
A new twist to adaptor proteins contributes to regulation of lymphocyte cell signaling. Trends Immunol (2008) 0.85
Dynamically driven protein allostery. Nat Struct Mol Biol (2006) 4.53
Structural basis for signal-sequence recognition by the translocase motor SecA as determined by NMR. Cell (2007) 3.06
Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol (2003) 2.64
Dynamic activation of an allosteric regulatory protein. Nature (2009) 2.61
Protein activity regulation by conformational entropy. Nature (2012) 2.53
Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol Cell (2007) 2.44
Structural basis for cAMP-mediated allosteric control of the catabolite activator protein. Proc Natl Acad Sci U S A (2009) 2.39
Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol (2006) 2.27
A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci (2005) 2.15
Disorder-order folding transitions underlie catalysis in the helicase motor of SecA. Nat Struct Mol Biol (2006) 2.06
ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts. J Cell Biol (2002) 2.05
Structure of the ubiquitin-binding zinc finger domain of human DNA Y-polymerase eta. EMBO Rep (2007) 1.91
Structural basis for protein antiaggregation activity of the trigger factor chaperone. Science (2014) 1.86
Protein dynamics and allostery: an NMR view. Curr Opin Struct Biol (2010) 1.75
The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res (2004) 1.37
Allosteric inhibition through suppression of transient conformational states. Nat Chem Biol (2013) 1.33
Signal peptides are allosteric activators of the protein translocase. Nature (2009) 1.28
Identification of the preprotein binding domain of SecA. J Biol Chem (2005) 1.25
Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol (2009) 1.13
Emerging roles for crk in human cancer. Genes Cancer (2010) 1.09
Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII. Nat Chem Biol (2012) 1.08
The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells. J Biol Chem (2005) 1.06
Preprotein-controlled catalysis in the helicase motor of SecA. EMBO J (2007) 1.06
C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF. J Cell Physiol (2005) 1.04
Solution structure of the Ubp-M BUZ domain, a highly specific protein module that recognizes the C-terminal tail of free ubiquitin. J Mol Biol (2007) 1.02
Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J Bacteriol (2006) 0.98
Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain. Oncogene (2005) 0.98
TAM receptors in apoptotic cell clearance, autoimmunity, and cancer. Autoimmunity (2013) 0.93
A NPxY-independent beta5 integrin activation signal regulates phagocytosis of apoptotic cells. Biochem Biophys Res Commun (2007) 0.93
Structural instability tuning as a regulatory mechanism in protein-protein interactions. Mol Cell (2011) 0.92
Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One (2010) 0.91
Substrate-activated conformational switch on chaperones encodes a targeting signal in type III secretion. Cell Rep (2013) 0.90
NMR studies of large protein systems. Methods Mol Biol (2012) 0.89
Characterization of the biochemical and biophysical properties of the phosphatidylserine receptor (PS-R) gene product. Mol Cell Biochem (2007) 0.89
Proapoptotic function of the nuclear Crk II adaptor protein. Biochemistry (2007) 0.89
The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells. J Biol Chem (2009) 0.88
ATG proteins mediate efferocytosis and suppress inflammation in mammary involution. Autophagy (2013) 0.87
Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton. Genes Cancer (2012) 0.86
Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells. Exp Hematol (2011) 0.86
Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis. J Biol Chem (2012) 0.86
Crk at the quarter century mark: perspectives in signaling and cancer. J Cell Biochem (2014) 0.83
Assembly of the translocase motor onto the preprotein-conducting channel. Mol Microbiol (2008) 0.82
1H, 15N and 13C resonance assignments of the tetratricopeptide repeat (TPR) domain of hSGT. J Biomol NMR (2003) 0.82
Real-time fluorescent resonance energy transfer analysis to monitor drug resistance in chronic myelogenous leukemia. Mol Cancer Ther (2010) 0.82
A novel role for the immunophilin FKBP52 in copper transport. J Biol Chem (2004) 0.81
High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis. J Immunol (2014) 0.80
Commentary: The carboxyl-terminal Crk SH3 domain: Regulatory strategies and new perspectives. FEBS Lett (2012) 0.79
An alternate conformation of the hyperthermostable HU protein from Thermotoga maritima has unexpectedly high flexibility. FEBS Lett (2004) 0.78
Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase. J Biomol NMR (2006) 0.78
Apoptosis: conserved roles for integrins in clearance. Curr Biol (2010) 0.76
NMR disentangles a dynamic disaggregase machinery. Nat Struct Mol Biol (2013) 0.75
Regeneration after death: Vav3 to the rescue. Blood (2009) 0.75
Monographs editor. Genes Cancer (2012) 0.75
1H, 15N and 13C resonance assignments of the SH2 domain of Bruton's tyrosine kinase. J Biomol NMR (2002) 0.75